These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31203818)

  • 1. Management of carbapenemase-producing Enterobacteriaceae in a low incidence area: A six-year experience in a university hospital.
    Emery A; Jeanvoine A; Bailly P; Gbaguidi-Haore H; Hocquet D; Bertrand X
    Infect Control Hosp Epidemiol; 2019 Aug; 40(8):936-938. PubMed ID: 31203818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Active surveillance and control of carbapenemase-producing enterobacteriaceae in a non-acute rehabilitation hospital in Madrid].
    Romero Pisonero E; Vera Itoiz E; García Picazo L; Rodríguez Fernández J
    Rev Esp Geriatr Gerontol; 2020; 55(2):124-126. PubMed ID: 31879157
    [No Abstract]   [Full Text] [Related]  

  • 3. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
    Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR
    J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-based Assessment of the Effect of Contact Precautions Applied to Surveillance-detected Carriers of Carbapenemase-producing Enterobacteriaceae in Long-term Acute Care Hospitals.
    Toth DJA; Khader K; Beams A; Samore MH
    Clin Infect Dis; 2019 Sep; 69(Suppl 3):S206-S213. PubMed ID: 31517974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity.
    Castagnola E; Tatarelli P; Mesini A; Baldelli I; La Masa D; Biassoni R; Bandettini R
    J Infect Public Health; 2019; 12(2):270-274. PubMed ID: 30477920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control strategy for carbapenemase-producing Enterobacteriaceae in nursing homes: perspectives inspired from three outbreaks.
    Legeay C; Hue R; Berton C; Cormier H; Chenouard R; Corvec S; Birgand G
    J Hosp Infect; 2019 Feb; 101(2):183-187. PubMed ID: 30389597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetic acid as a decontamination method for ICU sink drains colonized by carbapenemase-producing Enterobacteriaceae and its effect on CPE infections.
    Smolders D; Hendriks B; Rogiers P; Mul M; Gordts B
    J Hosp Infect; 2019 May; 102(1):82-88. PubMed ID: 30579969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada
    Kohler PP; Melano RG; Patel SN; Shafinaz S; Faheem A; Coleman BL; Green K; Armstrong I; Almohri H; Borgia S; Borgundvaag E; Johnstone J; Katz K; Lam F; Muller MP; Powis J; Poutanen SM; Richardson D; Rebbapragada A; Sarabia A; Simor A; McGeer A;
    Emerg Infect Dis; 2018 Sep; 24(9):1674-1682. PubMed ID: 30124197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
    Asensio Á; Cantero M; Shaw E; Vergara-López S
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.
    French CE; Coope C; Conway L; Higgins JP; McCulloch J; Okoli G; Patel BC; Oliver I
    J Hosp Infect; 2017 Jan; 95(1):3-45. PubMed ID: 27890334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.
    Schneider A; Coope C; Michie S; Puleston R; Hopkins S; Oliver I
    BMC Health Serv Res; 2019 Oct; 19(1):689. PubMed ID: 31606053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions].
    Leenstra T; Bosch T; Vlek AL; Bonten MJM; van der Lubben IM; de Greeff SC
    Ned Tijdschr Geneeskd; 2017; 161():D1585. PubMed ID: 29076442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.
    Enfield KB; Huq NN; Gosseling MF; Low DJ; Hazen KC; Toney DM; Slitt G; Zapata HJ; Cox HL; Lewis JD; Kundzins JR; Mathers AJ; Sifri CD
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):810-7. PubMed ID: 24915208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
    Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.
    Fournier S; Lepainteur M; Kassis-Chikhani N; Huang M; Brun-Buisson C; Jarlier V;
    J Travel Med; 2012; 19(5):320-3. PubMed ID: 22943275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013).
    Daroukh A; Delaunay C; Bigot S; Ceci JM; Siddhoun N; Bukreyeva I; Raisin J; Porcheret H; Maisonneuve L; Bouldouyre MA
    Med Mal Infect; 2014 Jul; 44(7):321-6. PubMed ID: 25022890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of an infection control programme to limit the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Belgian university hospital.
    Christiaens G; Barbier C; Warnotte J; Mutsers J
    J Hosp Infect; 2008 Apr; 68(4):366-7. PubMed ID: 18329138
    [No Abstract]   [Full Text] [Related]  

  • 20. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018.
    Brolund A; Lagerqvist N; Byfors S; Struelens MJ; Monnet DL; Albiger B; Kohlenberg A;
    Euro Surveill; 2019 Feb; 24(9):. PubMed ID: 30862330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.